机构:[1]Hebei Med Univ, Hosp 4, Dept Med Oncol, Shijiazhuang, Hebei, Peoples R China临床科室肿瘤内科河北医科大学第四医院[2]Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China河北医科大学第四医院[3]Hebei Med Univ, Fouth Hosp, Shijiazhuang, Hebei, Peoples R China[4]Hebei Med Univ, Hosp 4, Dept Oncol, Shijiazhuang, Hebei, Peoples R China临床科室肿瘤内科河北医科大学第四医院
第一作者机构:[1]Hebei Med Univ, Hosp 4, Dept Med Oncol, Shijiazhuang, Hebei, Peoples R China[2]Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China[3]Hebei Med Univ, Fouth Hosp, Shijiazhuang, Hebei, Peoples R China[4]Hebei Med Univ, Hosp 4, Dept Oncol, Shijiazhuang, Hebei, Peoples R China
推荐引用方式(GB/T 7714):
Zhao Honghui,He Liyuan,Feng Li,et al.Gut microbiota and association with clinical response to anti-PD-1 based immunotherapy combined with chemotherapy in Chinese patients with lung cancer[J].JOURNAL OF CLINICAL ONCOLOGY.2022,40(16):doi:10.1200/JCO.2022.40.16_suppl.e21005.
APA:
Zhao, Honghui,He, Liyuan,Feng, Li,Fan, Zhisong,Wang, Long...&Wang, Yudong.(2022).Gut microbiota and association with clinical response to anti-PD-1 based immunotherapy combined with chemotherapy in Chinese patients with lung cancer.JOURNAL OF CLINICAL ONCOLOGY,40,(16)
MLA:
Zhao, Honghui,et al."Gut microbiota and association with clinical response to anti-PD-1 based immunotherapy combined with chemotherapy in Chinese patients with lung cancer".JOURNAL OF CLINICAL ONCOLOGY 40..16(2022)